Data as of Nov 4, 2026
70.150.27.0/24
No anonymizer space · no proxy exits in 30 daysSmith Drug Company · space held by AT&T Enterprises, LLC
Announcements
Less specific
Covering announcements
| Prefix | Origin | Type | Proxy exits | Holder | RPKI |
|---|---|---|---|---|---|
| 70.150.0.0/16 since Jul 2023 | AS6389 | Residential | 4 | AT&T Enterprises, LLC |
Registrations in this block
The registry's network records over the announcement: those covering it, widest first, then every record inside it, under its parent.
| Range | Addresses | Netname | Holder | Type | Created | Abuse contact |
|---|---|---|---|---|---|---|
| 70.146.0.0 - 70.151.255.255 | 393,216 | BELLSNET-BLK15 | AT&T Enterprises, LLC (AEL-360) · US | Direct Allocation | Jul 28, 2004 | [email protected] |
| └ 70.150.27.0/24 | 256 | BLS-70-150-27-0-24-1009090347 | Smith Drug Company (C02583712) · US | Reassigned | Sep 9, 2010 | [email protected] via BELLSNET-BLK15 |
A contact marked “via” is the registry's: the record names none of its own, so the registry hands down its parent's.
Network & registry
IPv4 market
Holder
- Organization
- AT&T Enterprises, LLC
- Handle
- AEL-360
- Range
- 70.146.0.0 - 70.151.255.255
- Registration type
- Direct Allocation
- Record created
- Jul 28, 2004
Origin network
AS19593
US
- Name
- Smith Drug Company
- Type
- Business
- Registered
- Dec 12, 2019
- Domain
- smithdrug.com
- Industry
- Freight, Shipment, and Postal Services
- Spamhaus ASN-DROP
- not listed
Routing timeline
Covering aggregate above, the prefix's own history below
Summary
Routing history
- Pattern
- Stable
- First seen
- May 2005
- Current origin since
- Feb 2020 · 6.7 yr
- Origin networks
- 3
- Last change of origin
- Feb 2020
Recorded history
History
- Handoffs
- 2
IRR
Route objects on the exact prefix
| Origin | Registry | Description | Maintainer | Modified |
|---|---|---|---|---|
| AS19593 | RADB | Proxy-registered route object | MAINT-AS2711 | Nov 13, 2023 |
Whois
Registration for this announcement
- Range
- 70.150.27.0/24
- Netname
- BLS-70-150-27-0-24-1009090347
- Registrant
- Smith Drug Company
- Organization
- Smith Drug Company (C02583712)
- Type
- Reassigned
- Handle
- NET-70-150-27-0-1
- Parent
- NET-70-146-0-0-2
- Created
- Sep 9, 2010
- RIR
- ARIN
- Country
- US
- Delegated
- Jul 28, 2004
- Status
- assigned
Report abuse
Abuse contact
- [email protected]
- Name
- abuse
- Phone
- +1-919-319-8167
- Handle
- ABUSE7-ARIN